MedTrace Logo

Memantine Treatment in Alzheimer's Disease Patients

NCT03168997 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 222

Last updated 2017-05-30

No results posted yet for this study

Summary

The aim of this study is to investigate whether there will be any efficacy difference of Memantine treatment in different cognitive severity AD patients stratified with BPSD

Conditions

  • Alzheimer Disease

Interventions

DRUG

Memantine Hydrochloride

Memantine Hydrochloride treatment according to clinical routine treatment

Sponsors & Collaborators

  • Wei Cuibai

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-15
Primary Completion
2018-09-30
Completion
2018-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03168997 on ClinicalTrials.gov